News

• Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
  01/12/2021 / 15:05 - GlobeNewswire
•  
• Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
  01/08/2021 / 13:00 - GlobeNewswire
•  
• Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
  12/23/2020 / 14:00 - GlobeNewswire
•  
• Recro Announces Executive Changes
  12/16/2020 / 13:00 - GlobeNewswire
•  
• Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
  12/07/2020 / 22:05 - GlobeNewswire
•  
• E. Commission OKs first 80M Moderna vaccine batch
  11/25/2020 / 13:03 - TeleTrader
•  
• High-Potency, Plant-Based Wellness: Dosecann Introduces Cannabis Capsules With Omega-Rich Ahiflower® Oil, A Truly Differentiated Product for the Wellness Consumer
  11/23/2020 / 13:30 - GlobeNewswire
•  
• Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal Vaccine Candidate for COVID-19
  11/10/2020 / 07:00 - GlobeNewswire
•  
• Ingredion to Acquire 100% Ownership in Joint Venture Accelerating Growth in Plant-Based Proteins
  11/01/2020 / 23:17 - GlobeNewswire
•  
• EMA: Moderna eligible for Marketing Authorization
  10/14/2020 / 14:26 - TeleTrader
•  
• Institutional Investor Research Publishes 2020 Europe Executive Team Rankings
  09/04/2020 / 07:00 - GlobeNewswire
•  
• Moderna jumps 11% as it starts COVID-19 vaccine trial
  07/27/2020 / 13:02 - TeleTrader
•  
• Ex-FDA head says US ahead of China in vaccine development
  05/24/2020 / 22:05 - TeleTrader
•  
• argenx reports first quarter 2020 financial results and provides business update
  05/14/2020 / 07:00 - GlobeNewswire
•  
• Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America, Europe and Asia
  04/13/2020 / 14:05 - GlobeNewswire